Farshid G, Dhatrak D, Gilhotra A, Koszyca B, et al. The impact of 2018 ASCO-CAP HER2 testing guidelines on breast cancer HER2 results. An audit of 2132 consecutive cases evaluated by immunohistochemistry and in situ hybridization. Mod Pathol 2020 May 4. pii: 10.1038/s41379-020-0555.
PMID: 32366941